InventisBio Co., Limited (SHA:688382)

InventisBio Statistics

Total Valuation

InventisBio has a market cap or net worth of CNY 12.75 billion. The enterprise value is 11.23 billion.

Market Cap	12.75B
Enterprise Value	11.23B

Important Dates

The last earnings date was Wednesday, April 15, 2026.

Earnings Date	Apr 15, 2026
Ex-Dividend Date	n/a

Share Statistics

InventisBio has 578.35 million shares outstanding. The number of shares has increased by 1.12% in one year.

Current Share Class	578.35M
Shares Outstanding	578.35M
Shares Change (YoY)	+1.12%
Shares Change (QoQ)	-9.70%
Owned by Insiders (%)	10.10%
Owned by Institutions (%)	36.91%
Float	397.25M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	341.83
PB Ratio	8.30
P/TBV Ratio	8.31
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-35.45
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-69.19

Financial Position

The company has a current ratio of 11.09, with a Debt / Equity ratio of 0.01.

Current Ratio	11.09
Quick Ratio	10.90
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.14
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -18.93% and return on invested capital (ROIC) is -12.16%.

Return on Equity (ROE)	-18.93%
Return on Assets (ROA)	-11.38%
Return on Invested Capital (ROIC)	-12.16%
Return on Capital Employed (ROCE)	-21.23%
Weighted Average Cost of Capital (WACC)	5.50%
Revenue Per Employee	201,566
Profits Per Employee	-1.71M
Employee Count	168
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

In the past 12 months, InventisBio has paid 239,526 in taxes.

Income Tax	239,526
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +2.65% in the last 52 weeks. The beta is 0.23, so InventisBio's price volatility has been lower than the market average.

Beta (5Y)	0.23
52-Week Price Change	+2.65%
50-Day Moving Average	21.08
200-Day Moving Average	30.03
Relative Strength Index (RSI)	54.94
Average Volume (20 Days)	21,753,330

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, InventisBio had revenue of CNY 37.29 million and -316.87 million in losses. Loss per share was -0.55.

Revenue	37.29M
Gross Profit	32.27M
Operating Income	-330.07M
Pretax Income	-316.63M
Net Income	-316.87M
EBITDA	-324.46M
EBIT	-330.07M
Loss Per Share	-0.55

Balance Sheet

The company has 1.53 billion in cash and 22.07 million in debt, with a net cash position of 1.51 billion or 2.62 per share.

Cash & Cash Equivalents	1.53B
Total Debt	22.07M
Net Cash	1.51B
Net Cash Per Share	2.62
Equity (Book Value)	1.54B
Book Value Per Share	2.66
Working Capital	1.50B

Cash Flow

In the last 12 months, operating cash flow was -155.44 million and capital expenditures -6.92 million, giving a free cash flow of -162.36 million.

Operating Cash Flow	-155.44M
Capital Expenditures	-6.92M
Depreciation & Amortization	5.60M
Net Borrowing	n/a
Free Cash Flow	-162.36M
FCF Per Share	-0.28

Margins

Gross Margin	86.54%
Operating Margin	-885.14%
Pretax Margin	-849.10%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

InventisBio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.12%
Shareholder Yield	-1.12%
Earnings Yield	-2.49%
FCF Yield	-1.27%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1